Chromosomal microarray (CMA)
SNP microarray for detection of copy number variants (deletions and duplications) at a resolution significantly higher than conventional karyotype. Used for developmental delay, autism, and congenital anomalies.
Clinical Area · Reproductive Genetics
Chromosomal and reproductive genetic testing
Reproductive genetics testing encompasses chromosomal microarray for developmental indications, pregnancy loss analysis, and selected genomic pathways for couples and families navigating reproductive decisions. Testing is coordinated through internationally accredited reference laboratories with local clinical support.
Pregnancy loss analysis
All-chromosome deletion/duplication analysis from products of conception. Provides a chromosomal explanation for miscarriage when available, supporting counseling and subsequent pregnancy planning.
Extended SNP microarray
The Bebegene panel covers hundreds of chromosomal abnormalities and over 1000 microdeletions/duplications — useful for broader chromosomal characterization when indicated.
Clinical indications
When to consider reproductive genetics testing
Developmental delay, intellectual disability, or autism spectrum disorder — CMA evaluation
Congenital anomalies identified prenatally or postnatally
Recurrent pregnancy loss — chromosomal analysis of products of conception
Couples undergoing IVF — preimplantation genetic testing pathway
Abnormal prenatal ultrasound findings requiring chromosomal context
Parental chromosomal rearrangement — offspring risk assessment
Available tests
Reproductive genetics tests through AC
3billion
Bebegene Extended (1001 Microdeletions)
SNP microarray covering hundreds of chromosomal abnormalities and 1001 microdeletions/duplications.
Specimen: EDTA whole blood
TAT: 10–14 days
EDGC
Chromosomal Microarray — EDGC (CMA)
Chromosomal microarray for developmental delay, autism spectrum disorder, congenital anomalies, and related indications.
Specimen: EDTA blood / gDNA / amniotic fluid
TAT: 12–18 days
EDGC
Pregnancy Loss (All Chromosome, NGS)
All-chromosome deletion/duplication analysis for products of conception and pregnancy loss evaluation.
Specimen: Streck cfDNA tube
TAT: 10–12 days
Reproductive genetics
Discuss a case or set up a pathway
For IVF centers, obstetricians, and clinical genetics teams. Share the clinical indication and specimen type — AC will help identify the appropriate testing route.
Suite 403, 133 Madina Munawara St, Amman, Jordan
+962 791 707 606 info@advancedconsensus.comMessage us on WhatsAppFor website inquiries, avoid patient names, national IDs, medical record numbers, or reports. Secure document exchange should happen through approved clinical channels.